title: Fetal toxic effects and angiotensin-II-receptor antagonists.
authors.forename: J
authors.initials: J
authors.lastname: Martinovic
authors.forename: A
authors.initials: A
authors.lastname: Benachi
authors.forename: N
authors.initials: N
authors.lastname: Laurent
authors.forename: F
authors.initials: F
authors.lastname: Daikha-Dahmane
authors.forename: M C
authors.initials: MC
authors.lastname: Gubler
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D019808:Losartan / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014633:Valine / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000804:Angiotensin II; D000068756:Valsartan; D014633:Valine; D019808:Losartan